Squarepoint’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.1K | Buy |
+13,675
| New | +$94.1K | ﹤0.01% | 2502 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2919 |
|
|
2024
Q4 | – | Sell |
-88,130
| Closed | -$315K | – | 2914 |
|
|
2024
Q3 | $315K | Buy |
88,130
+63,613
| +259% | +$227K | ﹤0.01% | 1970 |
|
|
2024
Q2 | $152K | Sell |
24,517
-30,043
| -55% | -$186K | ﹤0.01% | 2200 |
|
|
2024
Q1 | $515K | Buy |
+54,560
| New | +$515K | ﹤0.01% | 1654 |
|
|
2023
Q4 | – | Sell |
-58,900
| Closed | -$262K | – | 2652 |
|
|
2023
Q3 | $262K | Sell |
58,900
-41,891
| -42% | -$186K | ﹤0.01% | 2004 |
|
|
2023
Q2 | $333K | Sell |
100,791
-218,920
| -68% | -$722K | ﹤0.01% | 1817 |
|
|
2023
Q1 | $911K | Buy |
+319,711
| New | +$911K | ﹤0.01% | 1213 |
|
|
2022
Q3 | – | Sell |
-30,936
| Closed | -$152K | – | 2232 |
|
|
2022
Q2 | $152K | Buy |
30,936
+567
| +2% | +$2.79K | ﹤0.01% | 1799 |
|
|
2022
Q1 | $718K | Buy |
30,369
+11,140
| +58% | +$263K | ﹤0.01% | 1306 |
|
|
2021
Q4 | $340K | Buy |
+19,229
| New | +$340K | ﹤0.01% | 1802 |
|
|
2020
Q2 | – | Sell |
-13,878
| Closed | -$166K | – | 2245 |
|
|
2020
Q1 | $166K | Buy |
+13,878
| New | +$166K | ﹤0.01% | 1529 |
|